CD63 and lung carcinoma: Kristine et al. 91 developed an EV array that coupled 37 antibodies targeting lung cancer-related proteins and CD9, CD63, and CD81 antibody groups to explore circulating exosomes from healthy subjects and patients with lung cancer.